Literature DB >> 1914234

Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections.

D C Mabey1, M J Holland, N D Viswalingam, B T Goh, S Estreich, A Macfarlane, H M Dockrell, J D Treharne.   

Abstract

In order to study the relationship between cell-mediated immune responses to Chlamydia trachomatis and the pathogenesis of human chlamydial eye disease, we have measured the peripheral blood lymphocyte proliferative responses to whole chlamydial elementary bodies in 40 subjects with oculogenital chlamydial infection of varying severity, 13 subjects with genital chlamydial infections and 12 healthy seronegative controls. The mean stimulation index was significantly higher in those with oculogenital infections than in controls. There was a strong correlation between the response to C. trachomatis serotypes B and L1. We studied the relationship between proliferative responses and four clinical parameters: follicular conjunctivitis, papillary hypertrophy, corneal pannus and epithelial punctate keratitis, but were unable to show a significant association with any of these. Nor was there any association between proliferative response and serum antibody titre to C. trachomatis (pooled serotypes D-K), duration of disease or quantitative isolation of chlamydia from the conjunctiva. The depletion of CD8+ cells had no consistent effect on proliferative responses to serotype L1 in 13 subjects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914234      PMCID: PMC1554148          DOI: 10.1111/j.1365-2249.1991.tb05770.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Authors:  C D Rothermel; J Schachter; P Lavrich; E C Lipsitz; T Francus
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 5.  Human immune response and Chlamydia trachomatis infection.

Authors:  D Kunimoto; R C Brunham
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection.

Authors:  G I Byrne; B Grubbs; T J Marshall; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

7.  Sensitivity of mitomycin-C treated McCoy cells for isolation of Chlamydia trachomatis from genital specimens.

Authors:  R M Woodland; R P Kirton; S Darougar
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

8.  Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

Authors:  R P Morrison; R J Belland; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.

Authors:  R S Stephens; E A Wagar; G K Schoolnik
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.

Authors:  R P Morrison; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  4 in total

1.  Cell-mediated immune response during primary Chlamydia pneumoniae infection.

Authors:  S Halme; J Latvala; R Karttunen; I Palatsi; P Saikku; H M Surcel
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.

Authors:  H M Surcel; H Syrjälä; M Leinonen; P Saikku; E Herva
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.

Authors:  R L Bailey; M J Holland; H C Whittle; D C Mabey
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Current problems of perinatal Chlamydia trachomatis infections.

Authors:  Kei Numazaki
Journal:  J Immune Based Ther Vaccines       Date:  2004-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.